Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

As the Distinguished William S. C. Chang Endowed Chair in the UC San Diego Jacobs School of Engineering’s Department of ...

GRAIL faces financial challenges but holds significant growth potential with its Galleri cancer-screening test. Click here to ...

As you read this, a white box the size of a refrigerator is hurtling through space at 17,500 miles per hour (28,000 kph), ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, ...

Illumina has a long history of driving advancements in genomics, providing the tools and technologies that have ...

Short-read (Illumina) 16S-EZ - For genus/species identification of bacteria and archaea - Targeted sequencing of 16S rRNA gene (V3 & V4 regions) - Short-read (Illumina) Full Length 16S - For ...

Number of Hedge Fund Holders: 56 Illumina, Inc. (NASDAQ:ILMN) offers sequencing and array based solutions for genetic and ...

Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As ...

In the rapidly evolving field of genomics, a new class of non-coding RNAs has captured the attention of researchers worldwide - circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs are ...

2 Since then, aside from the Illumina/Grail transaction, the Commission called in a small number of concentrations. The ...